Literature DB >> 15168220

Intronic polymorphism of tryptophan hydroxylase and serotonin transporter: indication for combined effect in predisposition to suicide.

B Jernej1, J Stefulj, D Hranilovic, M Balija, J Skavic, M Kubat.   

Abstract

Indices of disturbed serotonergic neurotransmission are the most robust biological findings in suicide. Tryptophan hydroxylase (TPH) and 5-hydroxytryptamine transporter (5HTt) are the main regulators of 5HT signaling. Owing to the assumed functionality of intronic polymorphisms of TPH (218AC) and 5HTt (VNTR-2) genes, we investigated frequencies of concurrence of the TPH and 5HTt genotypes containing "lower activity" alleles (CC and 1010, respectively), in 192 suicide victims and 377 controls. Significant differences in frequencies of 5HTt and TPH genotype combinations were found between suicide victims and control subjects (p = 0.0156), with a clear dose-effect of the suspected ("lower activity") genotypes (p = 0.0046). Concurrent presence of the two, allegedly transcriptionally less active, variants of these genes seems to be in some kind of relation to the increased susceptibility to suicide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15168220     DOI: 10.1007/s00702-003-0114-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  9 in total

Review 1.  Further clarification of the contribution of the tryptophan hydroxylase (TPH) gene to suicidal behavior using systematic allelic and genotypic meta-analyses.

Authors:  Dawei Li; Lin He
Journal:  Hum Genet       Date:  2006-02-01       Impact factor: 4.132

Review 2.  Toward a biosignature for suicide.

Authors:  Maria A Oquendo; Gregory M Sullivan; Katherin Sudol; Enrique Baca-Garcia; Barbara H Stanley; M Elizabeth Sublette; J John Mann
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

3.  Inhibition of allergic inflammation by supplementation with 5-hydroxytryptophan.

Authors:  Hiam Abdala-Valencia; Sergejs Berdnikovs; Christine A McCary; Daniela Urick; Riti Mahadevia; Michelle E Marchese; Kelsey Swartz; Lakiea Wright; Gökhan M Mutlu; Joan M Cook-Mills
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-07-27       Impact factor: 5.464

Review 4.  The role of the serotonergic system at the interface of aggression and suicide.

Authors:  M Bortolato; N Pivac; D Muck Seler; M Nikolac Perkovic; M Pessia; G Di Giovanni
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

Review 5.  Molecular genetics of monoamine transporters: relevance to brain disorders.

Authors:  K Haddley; A S Vasiliou; F R Ali; U M Paredes; V J Bubb; J P Quinn
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

6.  Possible Association between Serotonin Transporter Gene Polymorphism and Suicide Behavior in Major Depressive Disorder.

Authors:  Hwa-Young Lee; Jin-Pyo Hong; Jung-A Hwang; Heon-Jeong Lee; Ho-Kyung Yoon; Bun-Hee Lee; Yong-Ku Kim
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

7.  The Life Span Model of Suicide and Its Neurobiological Foundation.

Authors:  Birgit Ludwig; Bhaskar Roy; Qingzhong Wang; Badari Birur; Yogesh Dwivedi
Journal:  Front Neurosci       Date:  2017-02-14       Impact factor: 4.677

8.  Association between TPH1 polymorphisms and the risk of suicide behavior: An updated meta-analysis of 18,398 individuals.

Authors:  Alma Delia Genis-Mendoza; Yazmín Hernández-Díaz; Thelma Beatriz González-Castro; Carlos Alfonso Tovilla-Zárate; Rosa Giannina Castillo-Avila; María Lilia López-Narváez; Miguel Ángel Ramos-Méndez; Humberto Nicolini
Journal:  Front Psychiatry       Date:  2022-07-19       Impact factor: 5.435

Review 9.  Association of TPH-1 and TPH-2 gene polymorphisms with suicidal behavior: a systematic review and meta-analysis.

Authors:  Thelma Beatriz González-Castro; Isela Juárez-Rojop; María Lilia López-Narváez; Carlos Alfonso Tovilla-Zárate
Journal:  BMC Psychiatry       Date:  2014-07-08       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.